Financhill
Back

Ocugen Quote, Financials, Valuation and Earnings

Ocugen Price Quote

$0.77
0.00 (0.27%)
(Updated: December 21, 2024 at 5:40 AM ET)

Ocugen Key Stats

Sell
31
Ocugen (OCGN) is a Sell

Day range:
$0.73 - $0.80
52-week range:
$0.39 - $2.11
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
43.22
P/B ratio:
5.55%

Volume:
21.6M
Avg. volume:
5M
1-year change:
103.6%
Market cap:
$225.6M
Revenue:
$6M
EPS:
$-0.18

How Much Does Ocugen Make?

Data Unavailable

Is Ocugen Growing As A Company?

Data Unavailable

Ocugen Stock Price Performance

  • Did Ocugen Stock Go Up Last Month?
    Ocugen share price went down by -15.7% last month
  • Did OCGN's Share Price Rise Over The Last Year?
    OCGN share price rose by 103.6% over the past 1 year

What Is Ocugen 52-Week High & Low?

  • What Is Ocugen’s 52-Week High Share Price?
    Ocugen has traded as high as $2.11 over the past 52 weeks
  • What Is Ocugen’s 52-Week Low Share Price?
    Ocugen has traded as low as $0.39 over the past 52 weeks

Ocugen Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Ocugen?

Data Unavailable

Is Ocugen Cash Flow Positive?

Data Unavailable

Ocugen Return On Invested Capital

Data Unavailable

Ocugen Earnings Date & Stock Price

  • What Is Ocugen's Stock Price Today?
    A single share of OCGN can be purchased today for 0.77
  • What Is Ocugen’s Stock Symbol?
    Ocugen trades on the nasdaq under the ticker symbol: OCGN
  • When Is Ocugen’s Next Earnings Date?
    The next quarterly earnings date for Ocugen is scheduled on April 2, 2025
  • When Is OCGN's next ex-dividend date?
    Ocugen's next ex-dividend date is December 22, 2024
  • How To Buy Ocugen Stock?
    You can buy Ocugen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Ocugen Competitors

  • Who Are Ocugen's Competitors?
    Below is a list of companies who compete with Ocugen or are related in some way:
    • Cytokinetics Inc (CYTK)
    • Mirum Pharmaceuticals Inc (MIRM)
    • enVVeno Medical Corp (NVNO)
    • Scholar Rock Holding Corp (SRRK)

Ocugen Dividend Yield

Data Unavailable

Ocugen Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: -69.29% 278.67%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable